CSafe launches transport packaging for gene therapy market

By Damian Brett

Pharma packaging firm CSafe Global has launched a new product for the cell and gene therapy market.

CSafe said the passive AcuTemp Plus Series of packaging solutions has been designed with “proprietary, high-performance ThermoCor Vacuum Insulated Panels (VIP) to guarantee precise end-to-end control of internal payload temperatures”. 

“We are proud to expand our cold chain packaging offerings for the cell and gene therapy market, and have focused and invested significantly in R&D to develop best-in-class solutions to meet the demanding product requirements for this emerging class of medication,” stated Patrick Schafer, chief executive of CSafe Global.

“Test results of the new AcuTemp Plus Series have been very impressive with temperature performances outlasting other market available solutions by a large margin.”

Share this story

Related Topics

Latest pharma logistics news

DHL Supply Chain invests $70m in pharma and healthcare operations

By Rachelle Harry

DHL Supply Chain is continuing to invest in its life sciences and healthcare capabilities in North America. The company has…

Read More

Share this story

Emirates SkyCargo marks 30 years of operations in Singapore

By Rachelle Harry

Emirates SkyCargo is celebrating 30 years of operations in Singapore. During this time it has facilitated trade and supported business…

Read More

Share this story

Cargo.one launches tool to book passively cooled shipments

Online airfreight booking platform cargo.one has launched a new product category called Passive Temp Control that enables freight forwarders to compare…

Read More

Share this story